Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) traded down 0.3% during mid-day trading on Wednesday . The company traded as low as GBX 1,906.20 and last traded at GBX 1,906.20. 157 shares were traded during mid-day trading, a decline of 98% from the average session volume of 8,712 shares. The stock had previously closed at GBX 1,912.80.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Trading Down 0.5%
The business’s fifty day simple moving average is GBX 1,850.66 and its 200 day simple moving average is GBX 1,649.99. The stock has a market cap of £779.08 million and a price-to-earnings ratio of -1,726.55.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- What is the S&P 500 and How It is Distinct from Other Indexes
- Nike Beats on Earnings But Struggles in China and Faces Tariffs
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Is the AI Boom a Bubble? These 2 Dividend Stocks Say No
- How to Buy Cheap Stocks Step by Step
- 4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
